HaloFilm: a spray-on, re-chargeable, re-applicable antimicrobial coating

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

• Novel, bio-inspired chloramine for infection eradication in chronic wounds
• Novel, low corrosion, bio-compatible disinfectant with biofilm and residual efficacy
• Novel, bio-inspired chloramine to treat cutaneous fungal infections without resistance generation potential
• Novel Polymer Additives for Infection Control Intravenous Catheters
• Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

• Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail
• A first-in-class product for the clearance of high-risk human papillomaviruses
• A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
• Optimization, Pharmacokinetics, and Efficacy of an IgG Protease for the Treatment of Immune Thrombocytopenia and Other IgG-Mediated Autoimmune Diseases
• Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients

Research funding history

13 SBIR/STTR records share this UEI (2020–2025). Reported award amounts total $6,629,244. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation, Department of Agriculture, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards